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Abstract
OBJECTIVE: To investigate the influence and mech-
anism of salvianolic acid B (SalB) on apoptosis inhi-
bition in rat bone marrow-derived mesenchymal
stem cells (BMSCs) induced by hypoxia and serum
deprivation (hypoxia/SD).
METHODS: SalB concentration of 0.1, 1, 10 or 100
mg/L (drug groups) were investigated for their abili-
ty to inhibit apoptosis in rat BMSCs. BMSCs in both
the apoptosis model and drug groups were cul-
tured under hypoxic conditions for 6 h, after which
cell apoptosis and change in mitochondrial mem-
brane potential (MMP) were detected using flow cy-
tometry. Activation of caspase-3 was detected us-
ing western blot analysis.
RESULTS: Hypoxia/SD induced apoptosis in rat BM-
SCs. The early apoptosis rate was lower in the drug
groups compared to the apoptosis model group
(P<0.05). SalB was found to inhibit the reduction in
MMP and decrease the activation of caspase-3.
CONCLUSION: 0.1, 1 and 10 mg/L of SalB inhibits
activation of caspase-3 and early apoptosis of rat
BMSCs induced by hypoxia/SD and could therefore
enhance the survival rate of grafted stem cells.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Myocardial cell apoptosis and cardiac function failure,
caused by ischemic heart disease, are common causes
for mortality. Bone marrow-derived mesenchymal stem
cell (BMSC) grafting has good prospects for clinical ap-
plication in repairing cardiac muscle and restoring car-
diac function. However, low survival rate of grafted
BMSCs [1,2] greatly restricts the use of this therapeutic
approach. Danshen (Radix Salviae Miltiorrhizae) has
good curative effects on various types of ischemic heart
disease. SalB, a main ingredient of Danshen, was used
to investigate the mechanism of Danshen in the body.
In this research, hypoxia/SD was induced to mimic the
micro-environment of ischemic cardiac muscle in order
to promote apoptosis of rat BMSCs, in order to deter-
mine the effect and mechanism of SalB apoptosis inhi-
bition in BMSCs.
MATERIALS ANDMETHODS
Reagents and instruments
SalB (Nanjing Tisiaime), Iscove's Modified Dulbecco's
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Medium (IMDM, Gibco BRL), excellent grade ox fe-
tus serum (Gibco BRL), trypsase (Gibco, USA),
Hoechst 33342 (Sigma), reagent kit for detecting apop-
tosis of Annexin V-FITC cells (Baosai Biological, Bei-
jing), hypoxia-culturing kit (Bio Mérieux Rsa, France),
Rhodamine 123 (Sigma), reagent kit for detecting acti-
vation of caspase-3 enzyme (Biovision), caspase-3 anti-
body, cleaved caspase-3 antibody and actin antibody
(Santa Cruz, USA), horse radish peroxidase (Zhong-
shan Biological Limited, Beijing), cell-culturing box
for CO2 at constant temperature (Jouan, France), fluo-
rescence/inverted microscope (Olympus, Japan) and
flow cytometry (BD Biosciences, USA).
Isolation and culture of BMSCs
The femur and tibia from a Sprague Dawley (SD) rat
were excised and cells were slowly flushed out from the
marrow cavity using culture medium prior to seeding
into a 75 cm2 culture flask. After 24 h, culture medium
was replaced. After 4-5 days culture and on reaching
70%-80% confluence, original passage BMSCs were
passaged at a ratio of 1:3 to generate second passage
cells. Cultured rat BMSCs were observed under an in-
verted microscope.
Determining the growth curve
The BMSCs (the second passage, P2) were seeded into
24 well plates at a density of 5000 cells/well. Cell
counts were carried out at days 2, 3, 4, 5, 6, 7 and 8 af-
ter seeding. Cells from 3 wells were used to determine
each cell count and mean values were used to deter-
mine the growth curve.
Experimental groups
Same passage BMSCs with similar growth characteris-
tics were obtained from 6 flasks and were randomly di-
vided into the following 6 groups: control group (com-
plete IMDM containing 15% fetal bovine serum),
apoptosis model group (serum-free IMDM) and 4
SalB treatment groups (serum-free IMDM with either
0.1, 1, 10 or 100 mg/L SalB). In the SalB treatment
groups, cells were cultured for 1 h with culture com-
plete medium containing the relevant concentration of
SalB. After an hour, cells were rinsed twice with phos-
phate buffered saline (PBS) and exposed to experimen-
tal condition for different concentrations SalB (0.1, 1,
10 or 100 mg/L) for 6 h in hypoxia/SD conditions.
The apoptosis model group and SalB treated groups
were put into boxes for culturing cells under hypoxic
conditions. After addition of a hypoxia catalyst, boxes
were immediately closed. Both the control group and
hypoxia-culture boxes were incubated in 5% CO2 at
37°C for 6 h.
Hoechst staining for observation of cell apoptosis
using inverted and fluorescence microscopy
Cells in the 6 groups were rinsed twice with PBS. After
addition of culture medium, Hoechst 33342 was add-
ed at a concentration of 0.1 mg/mL. Cells were protect-
ed from light and left at room temperature (r.t) for 10
min. An inverted microscope was used for observation
and photographs were obtained. A fluorescence micro-
scope was used to observe the state of cell apoptosis
and photographs were obtained.
Annexin V/ Propidium iodide (PI) staining to detect
cell apoptosis using flow cytometry
Cells in the 6 groups were centrifuged at the speed of
1000 rpm for 5 min at 4°C. Supernatants were discard-
ed and cells were suspended in PBS. This procedure
was repeated twice. Cells were suspended in 200 µL
Binding Buffer. 10 µL Annexin V-FIFC was added in
dark conditions at r.t for 15 min. 300 µL of Binding
Buffer and 5 µL of PI was added. Within 10 min, flow
cytometry was used for detection of living cells, early-,
moderate- and late-apoptotic cells and necrotic cells.
Rhodamine 123 dye to determine MMP (Δψm)
SalB-treated cells were collected, rinsed twice with PBS
and exposed to rhodamine 123 (10 mg/L) at 37°C for
30 min. MMP level was detected using flow cytometry.
Western blot to detect protein-expression level
SalB-treated cells were collected and protein was ex-
tracted. The Coomassie brilliant blue method was used
to detect the concentration of protein. SDS polyacryl-
amide gel electrophoresis was used to separate proteins
(50 g of sample per hole). Protein was electrically trans-
ferred to a fibrin nitrate membrane. Western blot analy-
sis was used to detect the level of expression of the acti-
vated section of caspase-3. The fibrin nitrate mem-
brane was immersed in TBST containing 5% skimmed
milk powder at 4°C overnight, rinsed with TBST and
exposed for one hour at r.t to the corresponding prima-
ry antibody. The membrane was rinsed 3 times for 10
min each at r.t with slow agitation in TBST. The mem-
brane was exposed for 90 min at r.t to secondary anti-
body conjugated to horse radish peroxidase. After rins-
ing, the membrane was developed in chemical lumines-
cence liquid, exposed onto X-ray film in a dark room
and fixed to observe target protein.
Statistical analysis
All the data are expressed as mean±standard deviation
(SD). A non-paired t test was used. P<0.05 was regard-
ed as a statistically significant difference.
RESULT
BMSC morphology
As shown in Figure 1, 24 h after cell seeding, a small
number of cells were observed growing on the flask sur-
face with extensions stretched out. Other cells with a
round, bright appearance, in absence of adhesion to
the surface, were also observed. With increased culture
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time, cells gradually stretched to become more elongat-
ed and the colony quantity increased. On day 3 of cul-
ture, the density of elongated cells and cell colony num-
ber was further increased. By day 5 of culture, the cell
volume was expanded, colonies were linked and conflu-
ence was about 70%-80% . Whirlpool-shaped growth
was observed, typical of BMSCs. Cell growth morphol-
ogies of the original, second, fourth and fifth passages
on day 5 were observed and compared. Second passage
cells grew evenly on the surface with elongated mor-
phology. Third and fourth passage cells were similar in
appearance, although blunter. The morphology of fifth
passage cells were not as elongate as other passage
cells's. Subsequent experiments therefore used second,
third and fourth passage BMSCs.
Growth curve of BMSCs
Figure 2 shows the growth curve of second passage BM-
SCs. On day 1, cells were in the latent period; on days
2-5, cell proliferation accelerated; on days 6 and 7, cell
growth gradually decelerated and cell growth began to
decline. All cells in the testing were on day 3-4 when
the cell density reached 80%.
Exposure of SalB to BMSCs enables apoptosis
inhibition after hypoxia/SD induction
Observation of SalB apoptosis inhibition of BMSCs
under inverted microscope: Figure 3 shows that con-
trol group cells grew vigorously with an elongated mor-
phology, in a regular form and with a whirlpool appear-
ance. Cells in the apoptosis model group (hypoxia/SD)
and 100 mg/L SalB-treated group, were irregular, wrin-
kled, unsaturated and had shrunk. The number of cells
adhering to the surface was obviously decreased and
there was a large number of floating dead cells. Cells in
the groups treated with 0.1, 1 and 10 mg/L SalB, were
regular and elongated in morphology, with the typical
whirlpool appearance, in absence of large numbers of
floating dead cells. These results indicate that com-
pared to the apoptosis model group, BMSCs treated
with 0.1, 1 and 10 mg/L SalB are able to resist apopto-
sis induced by hypoxia/SD. However, the BMSCs treat-
ed with 100mg/L SalB were unable to resist apoptosis.
Observation of BMSCs apoptosis resistance with SalB
using Hoechst 33342 dye and fluorescence microscopy:
As shown in Figure 4, the karyon in cells from the con-
trol group is large with uniform quality and light blue
color. In cells from the apoptosis model and 100 mg/L
SalB-treated group, the karyon was shrunk and frag-
mented with irregular form and dark color. In cells
from the groups treated with 0.1, 1 and 10 mg/L SalB,
the karyon is similar to that in the control group and
the number of dead karyons is obviously decreased.
Annexin V/PI double dyed flow cytometry used to de-
tect apoptosis resistance in BMSCs by SalB: As shown
in Figure 5, after 6 h treatment with hypoxia/SD in the
apoptosis model group, the number of surviving cells
obviously decreased and early apoptosis increased
(32.01±4.16, P=0.00027). After treatment with SalB,
the number of early apoptotic cells was reduced. In the
groups treated with 0.1, 1, 10 and 100 mg/L SalB, the
early cell apoptosis rate was 12.78±1.64 (P=0.00087),
12.22 ± 1.73 (P=0.00080), 13.66 ± 4.07 (P=0.00274)
and 11.18±5.78 (P=0.00358) respectively. When com-
pared with the apoptosis model group, these values
were significantly reduced (P<0.01). However, there
was no obvious influence on moderate and late cell
apoptosis or on cell necrosis (P>0.05).
Original passage 24 h Original passage 3 days Original passage 5 days
Second passage 5 days Fourth passage 5 days Fifth passage 5 days
Figure 1 Cultured rat BMSCs (50×) observed under an inverted microscope.
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Figure 2 growth curve of rat BMSCs.
Control Hypoxia/SD 0.1 mg/L SalB+Hypoxia/SD
1 mg/L SalB+Hypoxia/SD 10 mg/L SalB+Hypoxia/SD 100 mg/L SalB+Hypoxia/SD
Figure 3 BMSCs exposed to different concentrations of SalB to observe apoptosis resistance using inverted microscopy (50×).
Control Hypoxia/SD 0.1 mg/L SalB+Hypoxia/SD
1 mg/L SalB+Hypoxia/SD 10 mg/L SalB+Hypoxia/SD 100 mg/L SalB+Hypoxia/SD
Figure 4 BMSCs exposed to SalB observed for apoptosis resistance using Hoechst 33342 and fluorescence microscopy (50×).
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Figure 5 AnnexinV/PI double dyed flow cytometry used to detect SalB apoptosis resistance in BMSCs.
Figure 6 Flow cytometry to detect the influence of SalB on
MMP in apoptosis induced BMSCs.
Figure 7 SalB inhibits activation of caspase-3 induced by hy-
poxia/SD.
Determining the mechanism of SalB apoptosis
resistance in BMSCs induced by hypoxia/SD
Influence of SalB on MMP of apoptotic cells: The
strength of fluorescence after the combination of Rho-
damine 123 with the mitochondrial matrix, indicates
the increase or decrease in negative MMP. As shown in
Figure 6, compared with the apoptosis model group,
SalB-treated groups had increased MMP, indicating
that the ability of SalB to inhibit apoptosis induced by
hypoxia/SD is guided by mitochondria.
SalB inhibits the activation of caspase-3 induced by hy-
poxia/SD: Western blot analysis was used to detect the
activation of caspase-3. As shown in Figure 7, there
was no activation of caspase-3 in control cells. In the
apoptosis model group, caspase-3 was expressed in
large amounts, indicative of apoptosis. Compared with
the apoptosis model group, groups treated with 0.1, 1,
10 and 100 mg/L of SalB had reduced levels of cas-
pase-3, indicating that SalB inhibits apoptosis to some
extent.
DISCUSSION
Treatment of ischemic heart disease, especially myocar-
dial infarction and other severe diseases, with stem cell
grafting has drawn much attention from clinical ex-
perts, becoming a prominent research area in recent
years. However, low survival rates of grafted BMSCs
has hindered its use. Enhancing the survival rate of
grafted BMSCs is a major clinical need that must be
addressed. It has been reported that the lipid-reducing
drugs, Lovastatin and glucocorticoid hormone (hydro-
cortisone), can effectively inhibit early apoptosis of
BMSCs induced by hypoxia/SD in vitro[4,5].
The traditional Chinese medicine drug, Danshen (Ra-
dix Salviae Miltiorrhizae), is widely used to treat diseas-
es of the cardiovascular system and has achieved good
curative effects in ischemic heart disease. It acts to ex-
pand coronary arteries, increase the blood flow
through coronary arteries, improve micro-circulation,
reduce the amount of oxygen consumption in cardiac
muscles and prevent and treat myocardial ischemia and
myocardial infarction [6-8]. It has been verified that SalB,
a main ingredient of Danshen, can promote stem cell
division and inhibit cell apoptosis in many cell
types [9,10]. At present however, there are no reports as to
whether SalB can inhibit apoptosis in BMSCs, which
could be significant in enhancing the survival rate of
grafted BMSCs.
Throughout this research, hypoxia/SD was used to imi-
tate the micro-environment of ischemic cardiac mus-
cle. This was achieved in vitro using a BMSCs apopto-
sis model of BMSCs. A 6 h time point was selected as
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the time of treatment with hypoxia/SD, where the
highest early BMSC apoptosis rate is observed. SalB
was investigated as an intervention drug to determine
its effect on apoptosis inhibition in BMSCs.
Cell apoptosis is characterized by cell shrinkage and ag-
glutination of karyon chromatin into plaques around
the nuclear membrane, resulting in a fragmented ap-
pearance. Morphological results obtained by microsco-
py and Hochest 33342 fluorescent dye, show that treat-
ment with 0.1, 1 and 10 mg/L SalB results in reduced
apoptosis in BMSCs and inhibited nuclear shrinkage
and fragmentation.
Statistical analysis of flow cytometry data indicate that
BMSC early apoptosis rates in the groups treated with
0.1, 1, 10 and 100 mg/L SalB are significantly lower
than in the apoptosis model group (P>0.01). However,
there is no obvious influence on BMSC moderate or
late apoptosis rates or on necrotic cells (P>0.05).
When using 100 mg/L of SalB, an anti-apoptosis effect
was not observed. In light of these data, we draw the
following conclusion: SalB at concentrations of 0.1-10
mg/L can inhibit early apoptosis in BMSCs induced by
hypoxia/SD, but has no effect on moderate or late
apoptosis.
The mitochondrion is a "factory" of energy metabo-
lism throughout the whole body and plays an impor-
tant role in cell apoptosis. Multiple stimuli contribute
to cell apoptosis. The reduction in MMP is considered
to be the earliest event during the process of cell apop-
tosis, before characteristics of nuclear apoptosis appear
(concentration of chromatin and break of DNA).
Once the mitochondrial membrane potential (ΔΨm)
has collapsed, cell apoptosis is irreversible.
Cytochrome C exists mainly in the gap of the mito-
chondrial membranes. Various apoptosis-stimulating
factors can induce its release into the cytoplasm to initi-
ate the process of apoptosis induced by caspase[11]. Previ-
ous researchers have reported that protection of mito-
chondrial function can obstruct cell apoptosis[12]. Re-
search into the genes that regulate and control cell
apoptosis has been widely focused on Bcl-2 and Cas-
pase-3[13]. It is confirmed that Bcl-2 exists on the mito-
chondrial membrane, nuclear membrane and endoplas-
mic reticular membrane. Caspase is considered the
most important proteinase in the process of cell apop-
tosis, hence acquiring the name, death proteinase.
Among the 14 family members discovered to date, cas-
pase-3 is the most important proteinase. The activation
of caspase-3 is a crucial downstream event within apop-
totic cascade. Activated caspase-3 functioned as the im-
portant executioner of apoptosis.
The experimental result shows that SalB may inhibit
the reduction in MMP caused by hypoxia/SD and re-
duce the activation of caspase-3 to inhibit BMSC apop-
tosis, thus further verifying the important role of pro-
tecting mitochondrial function for inhibiting apopto-
sis.
In summary, this is the first report that SalB, a single
ingredient of the traditional Chinese medicine drug,
Danshen, promotes apoptosis-resistance in BMSCs in-
duced by hypoxia/SD. This provides a novel approach
for enhancing the survival rate of grafted stem cells and
improving the curative effect of the stem cell graft in
ischemic heart disease, with great potential for clinical
use.
In the treatment of myocardial infarction and other
ischemic heart diseases with stem cell grafts, SalB could
be used to inhibit apoptosis of stem cells, to enhance
the survival rate of grafted stem cells and improve the
curative effect within clinical practice. Based on our re-
sults, the following approach is suggested: 1) Prior to
stem cell grafting, pre-treat cells with SalB to enhance
the survival rate of the grafted cells. 2) Prior to stem
cell grafting, patients should begin to take or be inject-
ed with a drug containing SalB as its main ingredient.
This will ensure levels of SalB in the body reach effec-
tive drug concentration for inhibiting apoptosis of
stem cells, clinically enhancing the curative effect of
the stem cell graft.
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